Sugimoto K - Search Results

1

Ustekinumab effectiveness in Crohn's disease with lesions in the intestines.

Tamura S, Asai Y, Ishida N, Miyazu T, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Furuta T, Sugimoto K. Tamura S, et al. Among authors: sugimoto k. Medicine (Baltimore). 2024 Apr 12;103(15):e35647. doi: 10.1097/MD.0000000000035647. Medicine (Baltimore). 2024. PMID: 38608112 Free PMC article.

2

Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission.

Miyazu T, Ishida N, Takano R, Tamura S, Yamade M, Hamaya Y, Tani S, Iwaizumi M, Osawa S, Furuta T, Sugimoto K. Miyazu T, et al. Among authors: sugimoto k. Medicine (Baltimore). 2021 Jul 23;100(29):e26550. doi: 10.1097/MD.0000000000026550. Medicine (Baltimore). 2021. PMID: 34398010 Free PMC article.

3

Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission.

Takano R, Osawa S, Uotani T, Tani S, Ishida N, Tamura S, Yamade M, Iwaizumi M, Hamaya Y, Furuta T, Miyajima H, Sugimoto K. Takano R, et al. Among authors: sugimoto k. World J Clin Cases. 2018 Dec 6;6(15):952-960. doi: 10.12998/wjcc.v6.i15.952. World J Clin Cases. 2018. PMID: 30568951 Free PMC article.

4

A rectal neuroendocrine tumor in a patient with Crohn's disease: a case report and literature review.

Suzuki K, Yamamoto M, Suzuki Y, Kawamura T, Kamishima M, Sakata M, Harada T, Kagami T, Tani S, Yamade M, Hamaya Y, Osawa S, Sugimoto K, Kurachi K, Takeuchi H. Suzuki K, et al. Among authors: sugimoto k. Clin J Gastroenterol. 2020 Jun;13(3):320-327. doi: 10.1007/s12328-019-01063-w. Epub 2019 Nov 8. Clin J Gastroenterol. 2020. PMID: 31705376 Review.

5

Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis.

Ishida N, Miyazu T, Takano R, Tamura S, Tani S, Kagami T, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Furuta T, Miyajima H, Sugimoto K. Ishida N, et al. Among authors: sugimoto k. BMC Gastroenterol. 2020 Apr 19;20(1):114. doi: 10.1186/s12876-020-01256-5. BMC Gastroenterol. 2020. PMID: 32306914 Free PMC article.

6

Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.

Sugimoto K, Ikeya K, Bamba S, Andoh A, Yamasaki H, Mitsuyama K, Nasuno M, Tanaka H, Matsuura A, Kato M, Ishida N, Tamura S, Takano R, Tani S, Osawa S, Nishihira J, Hanai H. Sugimoto K, et al. J Crohns Colitis. 2020 Dec 2;14(12):1693-1701. doi: 10.1093/ecco-jcc/jjaa097. J Crohns Colitis. 2020. PMID: 32412598 Clinical Trial.

7

Photodynamic Therapy Using Talaporfin Sodium for Local Failure after Chemoradiotherapy or Radiotherapy for Esophageal Cancer: A Single Center Experience.

Ishida N, Osawa S, Miyazu T, Kaneko M, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Furuta T, Sugimoto K. Ishida N, et al. Among authors: sugimoto k. J Clin Med. 2020 May 17;9(5):1509. doi: 10.3390/jcm9051509. J Clin Med. 2020. PMID: 32429571 Free PMC article.

8

Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker.

Ishida N, Miyazu T, Matsuura T, Takano R, Tamura S, Kagami T, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Furuta T, Sugimoto K. Ishida N, et al. Among authors: sugimoto k. Int J Colorectal Dis. 2020 Sep;35(9):1729-1739. doi: 10.1007/s00384-020-03636-5. Epub 2020 May 29. Int J Colorectal Dis. 2020. PMID: 32472230

9

The effect of early trough level of infliximab on subsequent disease course in patients with Crohn disease: A prospective cohort study.

Ishida N, Miyazu T, Sugiyama T, Tamura S, Kagami T, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. Ishida N, et al. Among authors: sugimoto k. Medicine (Baltimore). 2020 Jul 17;99(29):e21226. doi: 10.1097/MD.0000000000021226. Medicine (Baltimore). 2020. PMID: 32702894 Free PMC article.

10

Improvement in Ulcerative Colitis by Administration of Benralizumab for Comorbid Refractory Bronchial Asthma: A Novel Clinical Observation.

Sugimoto K, Fujita S, Miyazu T, Ishida N, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Furuta T, Osawa S. Sugimoto K, et al. Inflamm Bowel Dis. 2021 Jan 1;27(1):e3-e4. doi: 10.1093/ibd/izaa225. Inflamm Bowel Dis. 2021. PMID: 32812020 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,400 results

Search Page